Hagop Kantarjian will be awarded the American Society of Clinical Oncology’s 2023 David A. Karnofsky Memorial Award for his contributions to leukemia clinical research and his dedication to improving the lives of patients.
Anaeze Offodile II was named chief strategy officer at Memorial Sloan Kettering Cancer Center. He will begin his role on May 1.
Fox Chase Cancer Center and Temple Health established the Fox Chase-Temple Urologic Institute, an initiative that will concentrate on both benign and oncologic urology.
Jason Sicklick was appointed co-leader of the Structural and Functional Genomics Research Program at UC San Diego Moores Cancer Center.
Leslie A. Crews was named co-leader of the Moores Cancer Center Hematologic Malignancies Program, joining current co-leader, Thomas Kipps, professor of medicine and Evelyn and Edwin Tasch Chair in Cancer Research.
Deborah DeasKaren E. KnudsenDavid ReeseKeith R. YamamotoDeborah Deas, Karen E. Knudsen, David Reese, and Keith R. Yamamoto were elected to the Research!America board of directors.
Susan G. Komen appointed nine medical and research experts to serve as advisors to the organization.
Children’s Hospital Los Angeles, Korea University Anam Hospital, Louisiana State University Health Sciences Center New Orleans, and the University of Miami Sylvester Comprehensive Cancer Center were selected as members of a worldwide consortium contributing genomic data to the American Association for Cancer Research’s Project GENIE.
American Cancer Society Cancer Action Network sent a letter to Speaker Kevin McCarthy and House Democratic Leader Hakeem Jeffries detailing concerns on provisions in the Limit, Save and Grow Act that would restrict access to affordable health care and risk progress in cancer research.
Hong-yu Li, a researcher with the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences, recently received a five-year, $3.19 million grant from NCI to work toward advancing therapeutic treatments for certain types of cancer.
